Monday, November 13, 2023
- 9:00AM-11:00AM
-
Abstract Number: 0900
Complement Deposition on Extracellular Mitochondria Induces Platelet Activation in Vitro
(0899–0933) SLE – Etiology & Pathogenesis Poster- 9:00AM-11:00AM
-
Abstract Number: 0899
Complement Factor I (CFI) Gene Expression by Kidney Tubular Cells Is Increased in Lupus Nephritis Patients with Interstitial Fibrosis and Tubular Atrophy
(0899–0933) SLE – Etiology & Pathogenesis Poster- 9:00AM-11:00AM
-
Abstract Number: 1396
Comprehensive Evaluation of the Digital Annular Pulleys: From Ultrasonographical to Anatomical and Histological Evaluation with Special Focus on the Entheses
(1383–1411) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Imaging & AS- 9:00AM-11:00AM
-
Abstract Number: 1347
Continuing Biologic DMARDs During Pregnancy in Women with Rheumatic Disease Was Not Associated with Increased Unfavorable Pregnancy Outcomes, Serious Infections, and Adverse Effects of Vaccination
(1345–1364) Reproductive Issues in Rheumatic Disorders Poster II- 9:00AM-11:00AM
-
Abstract Number: 1016
Cost-related Medication Burden for Patients with and Without Systemic Autoimmune Rheumatic Diseases
(1013–1032) Healthcare Disparities in Rheumatology Poster II: Socioeconomic Determinants- 9:00AM-11:00AM
-
Abstract Number: 1141
COVID-19 Vaccination Status and Adverse Events Following SARS-CoV-2 Vaccine in Autoimmune Inflammatory Rheumatic Disease (AIRD) Patients: A Single Center Experience
(1124–1154) Miscellaneous Rheumatic & Inflammatory Diseases Poster II- 9:00AM-11:00AM
-
Abstract Number: 1297
COVID-19 Vaccination-related Delayed Adverse Events Among Patients with Rheumatoid Arthritis: Results from the COVAD Study
(1264–1307) RA – Diagnosis, Manifestations, and Outcomes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1017
Cross Country Differences in b/tsDMARD Prescription Behavior: Associations Between Socioeconomics, Real World b/tsDMARD Use and Disease Outcomes
(1013–1032) Healthcare Disparities in Rheumatology Poster II: Socioeconomic Determinants- 9:00AM-11:00AM
-
Abstract Number: 1249
Cross-Sectional Associations of Emotional Distress and Cardiovascular Health in Juvenile Lupus and Dermatomyositis
(1221–1255) Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease- 9:00AM-11:00AM
-
Abstract Number: 1039
Cross-Sectional Associations of Ultrasound Features with Symptom Outcomes at the Knee: A Community-based Study
(1033–1051) Imaging of Rheumatic Diseases Poster I- 9:00AM-11:00AM
-
Abstract Number: 1500
Cumulative Infections by Week 52 Among Patients with SLE: A Summary of Data from Placebo-Controlled Belimumab Studies
(1488–1512) SLE – Treatment Poster II- 9:00AM-11:00AM
-
Abstract Number: 1170
Damage Accrual in Idiopathic Inflammatory Myopathies: Data from a Monocentric Cohort and Impact on Patients’ Quality of Life
(1155–1182) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II- 9:00AM-11:00AM
-
Abstract Number: 0887
Dapagliflozin Modulates Inflammation and Germinal Centers in Lupus by Increasing Regulatory T Cells
(0886–0898) SLE – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 1557
De Novo Manifestations During Adalimumab Treatment in Behçet Syndrome